CAG repeat length in the androgen receptor gene is related to age at diagnosis of prostate cancer and response to endocrine therapy, but not to prostate cancer risk

British Journal of Cancer

Volumn 81, Issue 4, 1999, Pages 672-676

  Bratt, O ^a   Borg, A ^a   Kristoffersson, U ^a   Lundgren, R ^a   Zhang, Q X ^a   Olsson, H ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Androgen receptor; Cancer risk; Epidemiology; Genetics; Prostatic neoplasms

Indexed keywords

ANDROGEN RECEPTOR; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGE; AGED; ALLELE; AMINO TERMINAL SEQUENCE; ARTICLE; CANCER HORMONE THERAPY; CANCER RISK; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; RECEPTOR GENE; SWEDEN; TRANSACTIVATION;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; GONADOTROPIN-RELEASING HORMONE; HUMANS; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; RISK; TRINUCLEOTIDE REPEATS;

EID: 0032885741     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690746     Document Type: Article

References (29)

1. Bratt O, Kristoffersson U, Lundgren R and Olsson H (1999) Familial and hereditary prostate cancer in southern Sweden. A population-based case-control study. Eur J Cancer 35: 272-277
2. Bratt O, Kristoffersson U, Olsson H and Lundgren R (1998) Clinical course of early onset prostate cancer with special reference to family history as a prognostic factor. Eur Urol 34: 19-24
3. Carter BS, Beaty TH, Steinberg GD, Childs B and Walsh PC (1992) Mendelian inheritance of familial prostate cancer. Proc Natl Acad Sci USA 89: 3367-3371
4. Carter BS, Bova G, Beaty TH, Steinberg GD, Childs B, Isaacs W and Walsh PC (1993) Hereditary prostate cancer: epidemiologic and clinical features. J Urol 150: 797-802
5. Chamberlain N, Driver E and Miesfeld R (1994) The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acid Res 22: 3181-3186
6. Dijkman G and Debruyne F (1996) Epidemiology of prostate cancer. Eur Urol 30: 281-295
7. Giovannucci E, Stampfer M, Krithivas K, Brown M, Brufsky A, Talcott J, Hennekens C and Kantoff P (1997) The CAG repeat within the androgen receptor gene and its relationship to prostate cancer. Proc Natl Acad Sci USA 94: 3320-3323
8. Grönberg H, Damber J-E, Jonsson H and Lenner P (1994) Patient age as a prognostic factor in prostate cancer. J Urol 152: 892-895
9. Hakimi J, Roadinelli R, Schoenberg M and Barrack E (1996) Andogen-receptor gene structure and function in prostate cancer. World J Urol 14: 329-337
10. Hakimi J, Schoenberg M, Rondinelli R, Piantadosi S and Barrack E (1997) Androgen receptor variants with short glutamíne or glycine repeats may identify unique subpopulations of men with prostate cancer. Clin Cancer Res 3: 1599-1608
11. Hardy D, Scher H, Bogenreider T, Sabbatini P, Zhang Z-F, Nanus D and Catterall J (1996) Androgen receptor CAG repeat lengths in prostate cancer: correlation with age of onset. J Clin Endocrinol Metab 81: 4400-4405
12. Hayes RB, Liff JM, Pottern LM, Greenberg RS, Schoenberg JB, Schwartz AG, Swanson GM, Silverman DT, Morris Brown L, Hoover RN and Fraumeni JF (1995) Prostate cancer risk in U.S blacks and whites with a family history of cancer. Int J Cancer 60: 361-364
13. Ingles S, Ross R, Yu M, Irvine R, La Pera G, Haile R and Coetzee G (1997) Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor. J Natl Cancer Inst 89: 166-170
14. Irvine R, Yu M, Ross R and Coetzee G (1995) The CAG and GGC microsatellites of the androgen receptor gene are in linkage disequilibrium in men with prostate cancer. Cancer Res 55: 1937-1940
15. Kazemi-Esfarjani P, Trifiro M and Pinsky L (1995) Evidence for a repressive function of the long polyglutamine tract in the human androgen receptor: possible pathogenetic relevance for the (CAG)n-expanded neuronopathies. Hum Mol Genet 4: 523-527
16. Keetch DW, Rice JP, Suarez BK and Catalona WJ (1995) Familial aspects of prostate cancer: a case control study. J Urol 154: 2100-2102
17. La Spada A, Wilson E, Lubahn D, Harding A and Fischbeck K (1991) Androgen receptor gene mutations in X-linked spinal and bulbar muscular dystrophy. Nature 352: 77-79
18. Lesko S, Rosenberg L and Shapiro S (1996) Family history and prostate cancer risk. Am J Epidemiol 144: 1041-1047
19. Lubahn D, Brown T, Simental J, Higgs H, Migeon C, Wilson E and French F (1989) Sequence of the intron/exon junctions of the coding region of the human androgen receptor gene and identification of a point mutation in a family with complete androgen insensitivity. Proc Natl Acad Sci USA 86: 9534-9538
20. Monroe K, Yu M, Kolonel L, Coetzee G, Wilkens L, Ross RK and Henderson B (1995) Evidence of an X-linked or recessive genetic component to prostate cancer risk. Nature Med 1: 827-829
21. Narod S, Dupont A, Cusan L, Diamond P, Gomez J-L, Suburu R and Labrie F (1995) The impact of family history on early detection of prostate cancer (letter). Nature Med 1: 99-101
22. Rinker-Schaeffer C, Partin A, Isaacs W, Coffey D and Isaacs J (1994) Molecular and cellular changes associated with the acquisition of metastatic ability by prostatic cancer cells. Prostate 25: 249-265
23. Ross R, Pike M, Coctzee G, Reichardt J, Yu M, Feigelson H, Stanczyk F, Kolonel L and Henderson B (1998) Androgen metabolism and prostate cancer: establishing a model of genetic susceptibility. Cancer Res 58: 4497-4504
24. Schaid D, McDonnel S, Blute M and Thibodeau S (1998) Evidence for autosomal dominant inheritance of prostate cancer. Am J Hum Genet 62: 1425-1438
25. Smith JR, Freije D, Carpten JD, Grönberg H, Xu J, Isaacs SD et al (1996) Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search. Science 274: 1371-1374
26. Stanford J, Just J, Gibbs M, Wicklund K, Neal C, Blumenstein B and Ostrander E (1997) Polymorphic repeats in the androgen receptor gene: molecular markers of prostate cancer risk. Cancer Res 57: 1194-1198
27. Tut T, Ghadeesy F, Trifiro M, Pinsky L and Yong E (1997) Long polyglutamine tracts in the androgen receptor are associated with reduced trans-activation, impaired sperm production, and male infertility. J Clin Endocrinol Metab 82: 3777-3782
28. Whittemore AS, Wu AH, Kolonel LN, John EM, Gallagher RP, Howe GR, West DW, Teh C-Z and Stamey T (1995) Family history and prostate cancer risk in black, white, and Asian men in the united States and Canada. Am J Epidemiol 141: 732-740
29. Xu J, Meyers D, Freije D, Isaacs S, Wiley K, et al (1998) Evidence for a prostate cancer susceptibility locus on the X chromosome (letter). Nature Genetics 20: 175-179